BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36319022)

  • 1. Joint Damage Over Time in Patients With Early Rheumatoid Arthritis Follows Trajectories Related to Distinct Courses of Disease Activity.
    Dumoulin QA; Verstappen M; van der Helm-van Mil AHM; van Steenbergen HW
    J Rheumatol; 2023 Apr; 50(4):573-575. PubMed ID: 36319022
    [No Abstract]   [Full Text] [Related]  

  • 2. Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen joints.
    Aletaha D; Smolen JS
    Arthritis Rheum; 2011 Dec; 63(12):3702-11. PubMed ID: 21953215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural joint damage and hand bone loss in patients with rheumatoid arthritis.
    Ørnbjerg LM
    Dan Med J; 2018 Mar; 65(3):. PubMed ID: 29510810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Misclassification of disease activity when assessing individual patients with early rheumatoid arthritis using disease activity indices that do not include joints of feet.
    Bakker MF; Jacobs JW; Kruize AA; van der Veen MJ; van Booma-Frankfort C; Vreugdenhil SA; Bijlsma JW; Lafeber FP; Welsing PM
    Ann Rheum Dis; 2012 Jun; 71(6):830-5. PubMed ID: 22128075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation and damage in an individual joint predict further damage in that joint in patients with early rheumatoid arthritis.
    Boers M; Kostense PJ; Verhoeven AC; van der Linden S;
    Arthritis Rheum; 2001 Oct; 44(10):2242-6. PubMed ID: 11665964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of radiographic joint damage in rheumatoid arthritis: independence of erosions and joint space narrowing.
    Smolen JS; van der Heijde DM; Aletaha D; Xu S; Han J; Baker D; St Clair EW
    Ann Rheum Dis; 2009 Oct; 68(10):1535-40. PubMed ID: 18957487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knee joint destruction driven by residual local symptoms after anti-tumor necrosis factor therapy in rheumatoid arthritis.
    Imagama T; Tanaka H; Tokushige A; Seki K; Sumiura S; Yamamoto M; Nagahiro Y; Taguchi T
    Clin Rheumatol; 2013 Jun; 32(6):823-8. PubMed ID: 23377200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiographic progression of large joint damage in patients with rheumatoid arthritis treated with biological disease-modifying anti-rheumatic drugs.
    Nakajima A; Aoki Y; Sonobe M; Takahashi H; Saito M; Terayama K; Nakagawa K
    Mod Rheumatol; 2016 Jul; 26(4):517-21. PubMed ID: 26473376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiographic changes and factors associated with subsequent progression of damage in weight-bearing joints of patients with rheumatoid arthritis under TNF-blocking therapies-three-year observational study.
    Matsushita I; Motomura H; Seki E; Kimura T
    Mod Rheumatol; 2017 Jul; 27(4):570-575. PubMed ID: 27589926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?
    Ciubotariu E; Gabay C; Finckh A;
    J Rheumatol; 2014 Aug; 41(8):1576-82. PubMed ID: 25028383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do radiographic joint damage and disease activity influence functional disability through different mechanisms? Direct and indirect effects of disease activity in established rheumatoid arthritis.
    Nair SC; Bijlsma JW; van der Werf JH; van der Veen MJ; Linn-Rasker SP; Vreugdenhil S; Lafeber FP; Welsing PM
    J Rheumatol; 2013 Sep; 40(9):1505-12. PubMed ID: 23818710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Early recognition of rheumatoid arthritis].
    van der Helm-van Mil AH; Posthumus MD
    Ned Tijdschr Geneeskd; 2011; 155(30-31):A2902. PubMed ID: 22085506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of tacrolimus on progression of joint damage in patients with rheumatoid arthritis.
    Motomura H; Matsushita I; Seki E; Mine H; Kimura T
    Int J Rheum Dis; 2014 Sep; 17(7):749-54. PubMed ID: 24251619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tocilizumab inhibits progression of joint damage in rheumatoid arthritis irrespective of its anti-inflammatory effects: disassociation of the link between inflammation and destruction.
    Smolen JS; Avila JC; Aletaha D
    Ann Rheum Dis; 2012 May; 71(5):687-93. PubMed ID: 22121130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab dissociates the tight link between disease activity and joint damage in rheumatoid arthritis patients.
    Aletaha D; Alasti F; Smolen JS
    Ann Rheum Dis; 2013 Jan; 72(1):7-12. PubMed ID: 22915619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early local swelling and tenderness are associated with large-joint damage after 8 years of treatment to target in patients with recent-onset rheumatoid arthritis.
    van den Broek M; Dirven L; Kroon HM; Kloppenburg M; Ronday HK; Peeters AJ; Kerstens PJ; Huizinga TW; Lems WF; Allaart CF
    J Rheumatol; 2013 May; 40(5):624-9. PubMed ID: 23547212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheumatoid Factor Is Associated With the Distribution of Hand Joint Destruction in Rheumatoid Arthritis.
    Terao C; Yamakawa N; Yano K; Markusse IM; Ikari K; Yoshida S; Furu M; Hashimoto M; Ito H; Fujii T; Ohmura K; Murakami K; Takahashi M; Hamaguchi M; Tabara Y; Taniguchi A; Momohara S; Raychaudhuri S; Allaart CF; Yamanaka H; Mimori T; Matsuda F
    Arthritis Rheumatol; 2015 Dec; 67(12):3113-23. PubMed ID: 26245322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound versus clinical joint level assessment to predict structural damage in rheumatoid arthritis patients receiving biological therapy: a prospective study.
    Minowa K; Ogasawara M; Matsuki-Muramoto Y; Kawamoto T; Yamaji K; Tamura N
    Clin Exp Rheumatol; 2020; 38(4):801. PubMed ID: 32141426
    [No Abstract]   [Full Text] [Related]  

  • 19. Reductions in Radiographic Progression in Early Rheumatoid Arthritis Over Twenty-Five Years: Changing Contribution From Rheumatoid Factor in Two Multicenter UK Inception Cohorts.
    Carpenter L; Norton S; Nikiphorou E; Jayakumar K; McWilliams DF; Rennie KL; Dixey J; Kiely P; Walsh DA; Young A;
    Arthritis Care Res (Hoboken); 2017 Dec; 69(12):1809-1817. PubMed ID: 28217885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should we redefine treatment targets in rheumatoid arthritis? Low disease activity is sufficiently strict for patients who are anticitrullinated protein antibody-negative.
    de Punder YM; Hendrikx J; den Broeder AA; Valls Pascual E; van Riel PL; Fransen J
    J Rheumatol; 2013 Aug; 40(8):1268-74. PubMed ID: 23729803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.